Merck & Co., Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $1.88 | $1.89 | $1.89 |
| Q2 2024 | 6 | $2.17 | $2.17 | $2.17 |
| Q3 2024 | 5 | $1.46 | $1.51 | $1.48 |
| Q4 2024 | 12 | $1.62 | $2.11 | $1.84 |
| Q1 2025 | 2 | $2.21 | $2.35 | $2.28 |
| Q2 2025 | 1 | $2.35 | $2.51 | $2.43 |
| Q3 2025 | 1 | $2.49 | $2.65 | $2.57 |
| Q4 2025 | 1 | $2.12 | $2.25 | $2.18 |
Merck & Co., Inc. Earnings Date And Information
Merck & Co., Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $1.57 earnings per share for the quarter, topping analysts' consensus estimates of $1.5 by $0.07. The company had revenue of 16.66 B for the quarter and had revenue of 60.12 B for the year. Merck & Co., Inc. has generated $0 earnings per share over the last year ($0.14 diluted earnings per share) and currently has a price-to-earnings ratio of 20.67. Merck & Co., Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based on prior year's report dates.
Merck & Co., Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | $1.25 | $16.47 B | $16.66 B | ||
| 08/05/2024 | Q2 2024 | $2.15 | $15.87 B | $16.16 B | ||
| 05/03/2024 | Q1 2024 | $1.88 | $15.78 B | |||
| 04/11/2024 | Q4 2023 | -$0.48 | $14.63 B | |||
| 11/03/2023 | Q3 2023 | $1.87 | $15.30 B | $15.96 B | ||
| 08/07/2023 | Q2 2023 | -$2.35 | $14.44 B | $15.04 B | ||
| 05/05/2023 | Q1 2023 | $1.11 | $14.49 B | |||
| 02/24/2023 | Q4 2022 | $1.19 | $13.83 B | |||
| 11/03/2022 | Q3 2022 | $1.28 | $14.07 B | $14.96 B | ||
| 08/04/2022 | Q2 2022 | $1.56 | $13.86 B | $14.59 B | ||
| 05/05/2022 | Q1 2022 | $1.70 | $15.90 B | |||
| 02/25/2022 | Q4 2021 | $1.49 | $13.52 B | |||
| 11/05/2021 | Q3 2021 | $1.81 | $12.32 B | $13.15 B | ||
| 08/09/2021 | Q2 2021 | $0.61 | $11.23 B | $11.40 B | ||
| 05/05/2021 | Q1 2021 | $1.26 | $10.63 B | |||
| 02/25/2021 | Q4 2020 | -$0.83 | $12.52 B | |||
| 11/05/2020 | Q3 2020 | $1.16 | $12.21 B | $10.93 B | ||
| 08/05/2020 | Q2 2020 | $1.19 | $10.40 B | $9.35 B | ||
| 05/06/2020 | Q1 2020 | $1.28 | $12.06 B | |||
| 02/26/2020 | Q4 2019 | $0.93 | $11.87 B |
Merck & Co., Inc. Earnings: Frequently Asked Questions
-
When is Merck & Co., Inc.'s earnings date?
Merck & Co., Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates.
-
Did Merck & Co., Inc. beat their earnings estimates last quarter?
In the previous quarter, Merck & Co., Inc. (:MRK) reported $1.57 earnings per share (EPS) to beat the analysts' consensus estimate of $1.5 by $0.07.
-
How can I listen to Merck & Co., Inc.'s earnings conference call?
The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online.
-
How can I read Merck & Co., Inc.'s conference call transcript?
The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online.
-
How much revenue does Merck & Co., Inc. generate each year?
Merck & Co., Inc. (:MRK) has a recorded annual revenue of $60.12 B.
-
How much profit does Merck & Co., Inc. generate each year?
Merck & Co., Inc. (:MRK) has a recorded net income of $60.12 B. Merck & Co., Inc. has generated $0.14 earnings per share over the last four quarters.
-
What is Merck & Co., Inc.'s price-to-earnings ratio?
Merck & Co., Inc. (:MRK) has a price-to-earnings ratio of 20.67 and price/earnings-to-growth ratio is -0.6.
